Brown Michael S's Form 4 filing
Regeneron Pharmaceuticals, Inc. (REGN) · filed Mar 31, 2022
- Accession no.
- 0001708138-22-000030
- Filed
- Mar 31, 2022
- Trade date
- Mar 29-30, 2022
- Filing delay
- 2 days
- Rule 10b5-1 plan
- Not on the form (before 2023)
This filing lists 4 non-derivative transactions and 2 derivative transactions. Open-market sales total $1.35M. It was filed 2 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Brown Michael SCIK 0001174475 | Director |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 29, 2022 | Common Stock | MOption exerciseAcquired | +1,522 | $374.12 | +$569,410.64 | 2,604 | Direct | |
| Mar 29, 2022 | Common Stock | SSaleDisposed | −1,522 | $699.00 | −$1,063,878 | 1,082 | Direct | |
| Mar 30, 2022 | Common Stock | MOption exerciseAcquired | +408 | $374.12 | +$152,640.96 | 1,490 | Direct | |
| Mar 30, 2022 | Common Stock | SSaleDisposed | −408 | $699.00 | −$285,192 | 1,082 | Direct |
Derivative securities (Table II)
Options, warrants, restricted stock units and similar. Shares are the underlying shares; price and value are for the derivative itself, and the holding after is in derivative units.
| Trade date | Security | Transaction | Underlying shares | Unit price | Value | Held after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 29, 2022 | Common Stock | MOption exerciseDisposed | −1,522 | $0.00 | $0 | 2,839 | Direct | |
| Mar 30, 2022 | Common Stock | MOption exerciseDisposed | −408 | $0.00 | $0 | 2,431 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
No transaction price on this filing refers to a footnote.